Marci English, head of biopharma and ophthalmology development at Astellas Pharma, said the FDA's change of heart will ...
Routine evaluation of meibomian glands, starting in childhood, is crucial for identifying and managing this progressive ...
Navigating regulatory hurdles in the U.S. and Europe, plus fierce competition from rival Apellis, Astellas’ geographic ...
The Food and Drug Administration (FDA) has expanded the labeling for Izervay™ (avacincaptad pegol intravitreal solution) to include longer-term ...
For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.
Age-related macular degeneration is the leading cause of vision loss in those who are age 50 or older. In fact, almost 20 million people in the U.S. have some type of age-related macular ...
The updated label allows physicians to prescribe Izervay without a limitation on duration for patients with geographic ...
Yemeni woman travels to UAE for life-changing treatment, reinforcing Abu Dhabi’s status as a global healthcare hub ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback